Findings showed a significantly greater proportion of patients treated with the SC induction regimen achieved clinical remission, clinical response, and endoscopic improvement compared with placebo.

AmgenNow offers evolocumab at a reduced price, bypassing insurer requirements, and supports the Trump administration's drug pricing efforts. The Most Favored Nation executive order aims to align US ...

Improvements across all patient reported outcomes (PROs) were observed from baseline to Week 8 in all PRO instruments utilized in the ABTECT induction trials evaluating bowel urgency, sleep ...

Trends in laryngeal cancer incidence and mortality: A comprehensive analysis of long-term and recent patterns with demographic disparities using Surveillance, Epidemiology, and End Results (SEER) data ...

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction ...